ABSTRACT
V iral infections of the central nervous system are comparably rare but potentially devastating conditions. Typically, neurotropic viruses may reach the central nervous system (CNS) by (i) the olfactory route, (ii) via the blood-brain barrier, (iii) by infecting infiltrating cells, or (iv) by axonal transport (1) . Viral clearance in non-neuronal tissues often involves cytolytic elimination of infected cells. However, owed to their longevity and low regeneration potential this is not a suitable option for the clearance of neurotropic viruses from infected neurons. Nevertheless, many viral infections can be cleared from the CNS without causing marked neurological damage. Obviously, this is conferred by immune mechanisms that clear virus from infected tissues, or that inhibit viral replication, without affecting structure and function of the nervous system (2) .
To analyze neuroinfection via the olfactory route, intranasal (i.n.) infection of mice with vesicular stomatitis virus (VSV) is broadly studied. VSV is a negative-strand RNA virus, which is distantly related to rabies virus. Unlike rabies virus, VSV is a highly cytopathic virus (3) . Upon i.n. instillation, VSV infects olfactory sensory neurons in the nasal mucosa and moves along axons to the glomerular layer of the olfactory bulb. There, virus spread is efficiently arrested by a type I interferon (IFN)-dependent mechanism (4) . Activation of astrocytes and astrogliosis were observed as early as 1 day postinfection (p.i.) and peaked around day 8. Significant microgliosis was not observed before day 3 (5) . Since type I IFN produced in the periphery does not readily cross the blood-brain barrier, it was speculated that upon i.n. VSV infection protective type I IFN was produced locally within the CNS. Although all nucleated cells are able to produce type I IFNs in vitro, plasmacytoid dendritic cells (pDCs) were shown to be important type I IFN producers in several viral infections (6, 7) . However, pDCs were reported to be absent from brain (8) . This raised the question which CNS cell subset would produce protective type I IFN upon i.n. VSV infection.
Previous studies showed that upon influenza and La Crosse virus infection, type I IFN was conveyed by parenchymal cells of the CNS such as microglia/macrophages, ependymal cells and neurons (9, 10) . Of note, all cells of the CNS are able to react to IFN stimulation (11) , although it is unclear how assessable cells in different areas of the CNS are for soluble factors such as cytokines. One recent report suggested that locally produced type I IFN might act as a long-distance effector (12).
Notably, among type I IFNs, IFN-␣ may exhibit toxic effects within the CNS as demonstrated by transgenic mice with brainspecific overexpression of IFN-␣. Such mice displayed progressive encephalopathy that resembled the Aicardi-Goutièrez syndrome in humans (13) . Several studies implied that under steady-state conditions or during infectious disease, primarily IFN-␤ but not IFN-␣ was induced within the CNS (14) . Consequently, we here addressed whether upon i.n. VSV infection IFN-␤ and IFN-␣ were induced locally within the CNS and which subset of cells expressed IFN-␤. Our results indicate that protective IFN-␤ was primarily produced within the olfactory bulb by astrocytes and that this IFN exerted its protective effects throughout the brain. Most importantly, mice with an IFN-␤ deletion showed enhanced sensitivity to i.n. VSV infection, further highlighting the nonredundant role of intracerebral IFN-␤ in antiviral protection.
MATERIALS AND METHODS

Mice. IFN-␤
Ϫ/Ϫ (15), IFN-␤ ⌬␤-luc/wt (16) , and ISRE-eGFP (17) mice were backcrossed to the C57BL/6JOlaHsd background before intercrossing with other transgenic mouse strains. IFN-␤ ⌬␤luc/wt mice used for in vivo imaging were backcrossed to C57BL/6 albino background (18) . Tissue-specific reporter mice were generated by intercrossing IFN-␤ flox␤-luc/flox␤-luc animals with transgenic mice that express Cre tissue-specifically. To selectively enable the reporter system in neuroectrodermal cells, neurons, astrocytes, or oligodendrocytes, Nes-Cre (22) were used, respectively. Mice were kept under specific-pathogen-free conditions in the central mouse facility of the TWINCORE and at the Helmholtz Centre for Infection Research. Unmutated congenic C57BL/6JOlaHsd mice, also referred to as wild-type (WT) mice, were purchased at Harlan-Winkelmann. Animal experiments were conducted in compliance with German federal and state legislation on animal experiments.
Viruses. VSV-Indiana (Mudd-Summers isolate), originally obtained from D. Kolakofsky (University of Geneva, Switzerland), was grown on BHK-21 cells. Virus was harvested from cell culture supernatants, and titers were determined by plaque formation on Vero cells.
Intranasal VSV infection and optical imaging. For i.n. infection, a total of 10 l of suspension containing VSV in phosphate-buffered saline (PBS) was pipetted into both nostrils of anesthetized mice. For fluorescence imaging mice were sacrificed and brains were analyzed in a CRI Maestro2 imaging system (INTAS). For in vivo imaging, luciferase reporter mice were intravenously injected with 150 mg/kg of D-luciferin in PBS (Perkin-Elmer), anesthetized with 2.5% Isofluran (Abbot), and monitored using an IVIS Spectrum CT (Perkin-Elmer). Photon flux was quantified using the Living Image 4.3.1 software. For ex vivo luciferase activity measurements from selected tissues, mice were transcardially perfused with PBS prior to sacrificing them. Then, the weight of tissue fragments was determined, and fragments were homogenized in reporter lysis buffer (Promega) using a FastPrep24 homogenator. Lysates were mixed with a BrightGlo luciferase assay system (Promega), and luminescence was detected using a Centro XS 3 plate reader (Barthold). Astrocyte isolation and stimulation. Astrocytes were purified from neonatal mice as described previously (23) . For stimulation experiments, astrocytes were plated at a density of 10 5 cells/ml in 12-well plates. After 24 h of cultivation, the medium was changed, and cells were stimulated with either poly(I·C) or VSV. After 18 h of incubation, cell-free supernatant was harvested and stored at Ϫ20°C.
Real-time PCR. For the analysis of interferon mRNA expression, mice were transcardially perfused with PBS, and brains were isolated and lysed in TRIzol (Life Technologies). RNA was isolated and purified with an RNeasy Mini Kit (Qiagen), and cDNA was synthesized using a QuantiTect reverse transcription kit (Qiagen) . To analyze IFN mRNA expression, an IFN-subtype-specific dual-probe TaqMan-PCR assay (QuantiFast probe assay [Qiagen] ) with the housekeeper gene ppia2 as a control was performed. All kits were used according to the manufacturer's protocol.
ELISA. To determine the IFN content of serum or cell culture supernatant, a mouse VeriKine IFN-␤ enzyme-linked immunosorbent assay (ELISA) kit (PBL), a mouse VeriKine-HS IFN-␤ ELISA kit (PBL), or a VeriKine mouse IFN-␣ ELISA kit (PBL) was used according to the manufacturer's protocols.
Statistical analysis. Data were analyzed using R (R Core Team 2014) deploying Dunnett-type simultaneous multiple contrast tests using functionalities provided by add-on package Multcomp (24) or GraphPad Prism 5.0 software.
RESULTS
In a previous study we observed normal pathogen control in IFN-␤ Ϫ/Ϫ mice infected intravenously (i.v.) with VSV (6). Here we revisited the role of IFN-␤ upon i.n. VSV infection. In confirmation, 12 and 24 h after i.v. infection with 2 ϫ 10 6 PFU of VSV, wild-type (WT) control mice, as well as IFN-␤ Ϫ/Ϫ mice, showed maximal IFN-␣ serum levels, which declined at later time points and reached background levels by day 2 (Fig. 1A, upper panel) . Interestingly, IFN-␤ was not detected in the sera of i.v.-infected WT mice at any time point tested, whereas i.v. injection with poly(I·C) induced short-lived serum IFN-␤ peaking ϳ6 h after the treatment (Fig. 1B, upper panel) . Two days after i.n. infection with 10 3 PFU of VSV, maximal IFN-␣ levels were detected in the sera of WT and IFN-␤ Ϫ/Ϫ mice that declined within the following 2 days to background levels (Fig. 1A , lower panel). Upon i.n. infection of WT mice, again no serum IFN-␤ was detected, whereas i.n. poly(I·C) treatment did induce detectable IFN-␤ responses (Fig.  1B , lower panel). These data showed that upon i.v. and i.n. VSV infection, high levels of IFN-␣, but not IFN-␤, were detected in the serum. Both WT and IFN-␤ Ϫ/Ϫ mice mounted IFN-␣ responses of similar magnitudes.
To address whether VSV infection induces local IFN-␤ responses that could not be detected in the serum by the available ELISA methods, we studied IFN-␤ reporter mice carrying one IFN-␤ allele in which the IFN-␤ was replaced by luciferase (IFN-␤ ⌬␤luc/wt ). It has been reported previously that in these mice luciferase expression is equivalent to IFN-␤ expression, and can be used as a direct measure of IFN-␤ expression (16) . We observed similar survival of IFN-␤ ⌬␤luc/wt and WT mice upon i.n. and i.v. VSV infection, respectively, indicating that the deletion of one IFN-␤ allele had no significant impact on the virus control (data not shown). One day after i.v. infection of IFN-␤ ⌬␤luc/wt with 2 ϫ 10 6 PFU of VSV, strong luciferase induction was observed in secondary lymphoid organs and particularly in the inguinal and cervical lymph nodes (Fig. 1C, left panels) . Upon i.n. challenge with 10 3 PFU of VSV, the strongest luciferase induction was detected 2 days p.i. (Fig. 1C, right panels) . Similar to the results obtained with i.v.-infected mice, i.n. infection induced the strongest luciferase induction in cervical lymph nodes (Fig. 1C , upper right panels). Interestingly, in the dorsal view of i.n. infected mice luciferase signals were also detected in the forehead region which reached maximal strength between days 3 and 4 p.i. (Fig. 1C , lower right panels, and Fig. 2A ).
To address whether luciferase signals detected in the forehead of i.n.-infected IFN-␤ reporter mice originated from cells within the CNS, IFN-␤ reporter mice were i.n. infected with 10 3 PFU of VSV; on day 4 the mice were sacrificed, and homogenates of different brain areas were analyzed for luciferase activity separately. Interestingly, high luciferase activity was only detected in the olfactory bulb, whereas in the cerebrum, cerebellum, and brain stem luciferase activity was ϳ1,000-fold lower (Fig. 2B) .
To 
IFN-␤
flox␤-luc/wt mice showed similar, but still moderately reduced, luciferase activity within the olfactory bulb compared to IFN-␤ ⌬␤luc/wt mice at 3 days p.i. (Fig. 2C ). These results indicated that ca. 87% of the luciferase signal detected in IFN-␤ ⌬␤-luc/wt mice had a neuroectodermal origin (Fig. 2D) . Notably, Syn1Cre ϩ/Ϫ IFN-␤ flox␤-luc/wt mice showed low and GFAPCre ϩ/Ϫ IFN-␤ flox␤-luc/wt mice showed enhanced luciferase activities, the latter of which was still reduced compared to that detected in IFN-␤ ⌬␤-luc/wt or NesCre ϩ/Ϫ IFN-␤ flox␤-luc/wt mice (Fig. 2C ). These data implied that upon i.n. VSV infection, astrocytes and to a lesser extent neurons expressed IFN-␤.
To confirm in an independent system that upon VSV treatment astrocytes can mount IFN-␤ responses, we enriched astrocytes from neonatal mixed glia cell cultures and infected them with VSV or stimulated them with the strong IFN inducer poly(I·C). After 18 h of incubation, cell-free supernatant was collected, and the interferon content was determined by ELISA methods. Upon VSV infection, enhanced IFN-␤ was detected (Fig. 2E ) that was still low compared to IFN-␤ responses induced by poly(I·C) (Fig. 2F) . Importantly, neither upon VSV nor poly(I·C) stimulation astrocytes produced IFN-␣2 or -␣4 (data not shown). Collectively, these experiments indicated that after i.n. VSV infection among neuroectodermal cells astrocytes and, to a lesser extent neurons, showed enhanced IFN-␤ expression, whereas oligodendrocytes did not contribute to IFN-␤ responses within the CNS. Nevertheless, it cannot be excluded that non-neuroectodermal cells of the CNS such as microglia also produced some IFN-␤.
Reverse transcription-PCR (RT-PCR) analysis of IFN-␤ and 10 different IFN-␣ subtypes revealed that, within 2 days after i.n. VSV instillation, primarily IFN-␤ was induced within CNS (Fig.  3A) . Interestingly, constitutive low-level IFN-␣2 expression was increased within 2 days after infection, whereas IFN-␣4 and IFN-␣5 were only moderately induced at this time point. Induction of other IFN-␣ subtypes was not detected (Fig. 3A) . Extended analysis of IFN-␤, IFN-␣2, IFN-␣4, and IFN-␣5 expression in different brain areas showed that the majority of IFN transcripts were found within the olfactory bulb (Fig. 3B) . These results were in line with the observation that in i.n.-infected reporter mice, luciferase induction was primarily detected within the olfactory bulb (compare Fig. 1C, Fig. 2B, and Fig. 3B ).
To address whether IFN-␤ that was locally induced within the olfactory bulb was only locally active or also showed long-distance effects, we performed experiments with ISRE-eGFP mice. In such mice type I IFN-stimulated cells display enhanced green fluorescent protein (eGFP) expression (17) . One, two, and three days after i.n. infection with 10 3 PFU of VSV, mice were sacrificed, and the brains were prepared and studied in a fluorescence imager. Already, at 1 day after i.n. infection, whole brains of ISRE-eGFP mice showed enhanced eGFP expression that further increased with time (Fig. 3C , left panels, and Fig. 3D, upper panel) . Of note, enhanced eGFP expression was not confined to the site of local IFN-␤ induction, i.e., the olfactory bulb, but was also found in distal brain areas. Importantly, ISRE-eGFP mice devoid of IFN-␤ (ISRE-eGFP ϩ/Ϫ IFN-␤ Ϫ/Ϫ ) did not show enhanced eGFP expression upon i.n. VSV challenge (Fig. 3C , right panels, and Fig. 3D , lower panel).
The data obtained thus far suggested that IFN-␤ played an important role within the CNS to constrain virus spread, whereas VSV infection did not appear to trigger abundant IFN-␤ serum levels. To address the role of IFN-␤ in peripheral infection compared to neuroinfection, we performed a thorough dose sensitivity infection study of WT and IFN-␤ Ϫ/Ϫ mice. WT controls and IFN-␤-deficient mice showed a very similar sensitivity to i.v. infection with 2 ϫ 10 6 , 2 ϫ 10 7 , 2 ϫ 10 8 , and 2 ϫ 10 9 PFU of VSV ( Fig. 4A and B) . Importantly, IFN-␤ Ϫ/Ϫ mice were significantly more vulnerable to i.n. VSV infection than WT controls, as indicated by 80% of WT mice surviving i.n. instillation of 10 3 PFU of VSV, whereas under such conditions all IFN-␤ Ϫ/Ϫ mice died ( Fig.  4C and D) . Along the same line, for several days following i.v. infection with 2 ϫ 10 6 PFU of VSV, no virus could be detected in the olfactory bulbs, cerebra, cerebella, and brain stems of WT mice (Fig. 4E, upper panel) . Similarly, also in IFN-␤ Ϫ/Ϫ mice hardly any virus was found (Fig. 4E, lower panel) . However, upon i.n. infection with 10 3 PFU of VSV, the brains of IFN-␤ Ϫ/Ϫ mice displayed significant virus burden that further increased over time (Fig. 4F, lower panel) , whereas WT animals were virus free (Fig.  4F, upper panel) .
DISCUSSION
Here we showed that, upon i.n. VSV infection, antiviral IFN-␤ was induced locally within the olfactory bulb by astrocytes and, to a lesser extent, by neurons. Although produced locally, IFN-␤ exhibited long-distance effects on distal brain areas. In addition, IFN-␤-deficient mice displayed enhanced sensitivity to i.n. VSV ⌬␤-luc/wt ) were i.n. infected with 10 3 PFU of VSV. On day 3 p.i., one mouse was exemplarily imaged in an in vivo imager, whereas the other mice were perfused with PBS to obtain blood-free tissues and sacrificed. The brains were dissected in olfactory bulbs, cerebra, cerebella, and brain stems, the tissues were lysed, and the luciferase activity was determined. (C) To study the identity of neuroectodermal cells, i.e., astrocytes, neurons, or oligodentrocytes, that were the main IFN-␤ producers within the CNS, tissue-specific reporter mice were used. These mice were i.n. infected with 10 3 PFU of VSV. At 4 days p.i., mice were perfused and sacrificed, and olfactory bulbs (OB), cerebra (CR), cerebella (CB), brain stems (BS), and cervical lymph nodes (CLN) were prepared. Tissues were lysed, and the luciferase activity was determined. The data from one representative experiment out of two to five independent ones are shown. For each data set, at least five mice per group were used. (D) Estimation of the luciferase signal obtained in the olfactory bulb of i.n.-infected NesCre ϩ/Ϫ IFN-␤ flox␤-luc/wt relative to IFN-␤ ⌬b-luc/wt mice. Astrocytes were isolated from mixed glial cultures of WT mice and treated with VSV at the indicated multiplicity of infection (MOI) (E) or with poly(I·C) (F) at the indicated final concentrations. After 18 h of incubation, cell-free supernatant was collected, and the IFN-␤ content was determined by ELISA methods. The combined data of three independent experiments are shown (***, P Ͻ 0.0001 [Dunnett-type multiple comparison procedure]).
infection, illustrating the biological significance of intracerebrally produced IFN-␤.
In many cell types, the immediate-early type I IFN response is dominated by IFN-␤ (25). Therefore, it was speculated that IFN-␤ has a central regulatory function in priming cells for the induction of IFN-␣ genes (26, 27) . Here we showed that upon i.v. VSV infection IFN-␣ responses of IFN-␤ Ϫ/Ϫ mice were only moderately delayed compared to WT mice, and overall resistance to VSV infection was not affected. Interestingly, under such conditions no serum IFN-␤ responses were detected. Correspondingly, i.n. VSV infection induced similar IFN-␣ serum responses in WT and IFN-␤ Ϫ/Ϫ mice. This is in line with previous findings that upon infection with VSV, Sindbis virus, or Friend virus, IFN-␣ induction was independent of IFN-␤ (6, 28, 29) .
Our in vivo imaging studies indicated that upon i.n. VSV instillation IFN-␤ was induced in the area of the foreheads of C57BL/6 reporter mice. Isolation of brains from such reporter mice and determination of luciferase activity within the different brain areas unequivocally revealed that IFN-␤ induction was only detected in the olfactory bulb but not in other brain areas. This observation was further confirmed by an independent method, i.e., by qPCR analysis of type I IFN mRNA induction. Of note, in an earlier study using BALB/c mice that were i.n. infected with VSV, no IFN-␤ induction was detected within the brain (30) . Nevertheless, others have also recently detected IFN-␤ induction within the olfactory bulb upon i.n. VSV infection of C57BL/6 mice (12). Despite local IFN-␤ induction, in the present study we could not reisolate live virus from the olfactory bulbs of i.n.-infected C57BL/6 mice (Fig. 4F) .
The analysis of tissue-specific reporter mice indicated that primarily astrocytes, and to a lesser extent neurons, showed IFN-␤ expression upon i.n. VSV infection. Our calculations implied that ca. 90% of locally induced IFN-␤ was expressed by neuroectodermal cells. However, since it is difficult to prove that NesCre ϩ/Ϫ mice show Cre expression in 100% of all neuroectodermal cells, it cannot be excluded that the percentage underestimates the role of neuroectodermal cells in mounting type I IFN responses within the CNS. Furthermore, it is still possible that non-neuroectodermal cells such as microglia contributed as well, although such a contribution would certainly be a minor one. The luciferase expression detected in astrocyte-specific reporter mice and neuronspecific reporter mice did not add up to the quantity of luciferase activity detected in neuroectodermal reporter mice. This presumably can be explained by the fact that GFAPCre ϩ/Ϫ mice express Cre only in a subset of astrocytes, notably activated astrocytes (21, 31) . Similarly, although Synapsin-1 is expressed in neurons of the olfactory bulb (32) and the deletion of Syn1Cre mice is highly selective, it is not very efficient. This might also result in a minor underestimation of the contribution of neurons to the overall IFN-␤ responses within the brain.
To address in an independent experimental setting whether upon VSV treatment astrocytes can mount IFN-␤ responses, we isolated astrocytes from mixed glial cultures and stimulated them with VSV or poly(I·C). Upon VSV infection, as well as poly(I·C) stimulation, IFN-␤ expression was significantly induced. Notably, astrocyte cultures stimulated with VSV showed enhanced IFN-␤ levels, although the absolute values were low compared to poly(I·C) stimulations. Importantly, VSV-or poly(I·C)-treated astrocytes did not produce IFN-␣. Thus, considering the above in vivo experiments with astrocyte-specific GFAPCre ϩ/Ϫ IFN-␤ flox␤-luc/wt reporter mice and the in vitro stimulation experiments with primary astrocytes, two independent lines of evidence supported the conclusion that upon VSV stimulation astrocytes are triggered to mount IFN-␤ responses.
Despite the fact that IFN-␤ was only locally induced within the olfactory bulb, we found long-distance IFNAR-signaling in distal brain parts such as the cerebrum and other brain areas. This observation was surprising because in our previous study we detected STAT1 phosphorylation as a measure of IFNAR signaling only within the glomerular layer of the olfactory bulb (4). This , and 8 days p.i., the mice were sacrificed, and the virus titers in the olfactory bulbs (OB), cerebra (CR), cerebella (CB), and brain stems (BS) were determined based on plaque formation. Five mice per genotype and time point were analyzed. discrepancy might be explained by the different readout systems. In our earlier study we analyzed IFNAR-triggered P-STAT-1 formation that is relatively short-lived and therefore can be easily missed. On the contrary, IFNAR-dependent eGFP-induction in ISRE-eGFP mice is a more robust readout simply due to the longevity of eGFP, which in previous studies was estimated to have a half-life of Ͼ1 day (33) .
Similarly, van den Pol et al. reported that upon i.n. VSV infection, IFN-␤, as well as IFN-2/3, expression was triggered within the olfactory bulb but not in the cerebellum and medulla. In contrast, ISG induction was detected in all brain areas tested (12). However, enhanced 2=,5=-oligoadenylate synthetase (OAS) induction was detected only in the olfactory bulb and not in other brain areas. This points toward particularly enhanced OAS triggering within the olfactory bulb. Such an enhanced IFNAR signaling within the olfactory bulb might also explain why we detected P-STAT-1 only in the granular layer of the olfactory bulb and not in distal brain areas. The observation that ISRE-eGFP mice devoid of IFN-␤ did not show enhanced eGFP expression upon i.n. VSV challenge (Fig. 3C, right panels) is explained by the absence of the dominating type I IFN of the CNS, i.e., IFN-␤. In addition, it is possible that due to the absence of IFN-␤ priming, no low-level IFN-␣ responses could be induced any more.
In line with previous studies analyzing various different kinds of viruses, systemic induction of IFN-␣ was not altered in IFN-␤ Ϫ/Ϫ mice. In infection studies, their phenotype was less severe than that of IFNAR Ϫ/Ϫ mice. This suggested that, in addition to IFN-␤, other type I IFN subtypes can take over regulatory functions in vivo (34) .
The data discussed thus far imply that within the CNS, IFN-␤ induction plays a key role in limiting virus spread. We found here that upon i.n. VSV infection, locally induced IFN-␤ expressed primarily by astrocytes protects the entire brain. The biological relevance of this phenomenon was illustrated by the significantly enhanced sensitivity of IFN-␤ Ϫ/Ϫ mice to i.n. VSV infection, whereas such mice were as resistant to i.v. infection as WT controls. Thus, localized IFN expression within the olfactory bulb resulted in IFNAR triggering of distal parts of the CNS and mediated protection against VSV infection. Although the biological importance of the apparent redundancy of type I IFNs remains unclear, we demonstrated here the CNS-specific essential role of IFN-␤ in VSV infection.
